Skip to main content
Fig. 1 | BMC Molecular and Cell Biology

Fig. 1

From: CTC together with Shh and Nrf2 are prospective diagnostic markers for HNSCC

Fig. 1

TCGA data analysis for Shh / Nrf2 gene expression in HNSCC patients. A The percentage (%) of HNSCC patients showing altered expression of Shh. B, C Expression of Shh in HNSCC based on sample type and gender. D, E Expression of Shh in HNSCC patients based on age group and tumor grade. F The percentage (%) of HNSCC patients showing altered expression of NFE2L2 (Nrf2). G, H Expression of Nrf2 in HNSCC based on sample type and gender. I, J Expression of Nrf2 in HNSCC patients based on age group and tumor grade. Shh and Nrf2 expressions were calculated in the number of transcripts per million. The expression pattern of Shh was checked based on the mRNA Z-score. **p-value < 0.005, ***p-value < 0.001, ****p-value < 0.0001

Back to article page